FDA inspection
Aldeyra Therapeutics, Inc.: FDA inspection ending Apr 28, 2023
FDA inspection 1204017 · Voluntary Action Indicated (VAI) · Lexington, MA
Key facts
| Inspection ID | 1204017 |
|---|---|
| Firm | Aldeyra Therapeutics, Inc. |
| FEI number | 3013989915 |
| Address | 131 Hartwell Ave Ste 320 |
| City | Lexington |
| State | MA |
| ZIP | 02421 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Apr 28, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data